NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1995-8218
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease ; day:9 ; month:2 ; year:2023 ; pages:1-13
Neuroscience bulletin ; (9.2.2023), 1-13
- Creator
-
Han, Qiu-Qin
Le, Weidong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12264-023-01023-y
- URN
-
urn:nbn:de:101:1-2023041321034824469056
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Han, Qiu-Qin
- Le, Weidong
- SpringerLink (Online service)
Other Objects (12)
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation
GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome
Neuroinflammation and protein pathology in Parkinson’s disease dementia
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation
GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome
Neuroinflammation and protein pathology in Parkinson’s disease dementia
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation
GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome
Neuroinflammation and protein pathology in Parkinson’s disease dementia
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells